Molbio Diagnostics' initial public offering received 70.26 times subscription on the final day of bidding on Wednesday last ...

Patients taking immune-suppressing therapies are at higher risk for neuroinvasive illness from ticks and mosquitoes.

According to MarketsandMarkets™, the Cancer Diagnostics Market is projected to reach USD 44.92 billion by 2031 from USD 29.86 billion in 2026, at a CAGR of 7.0% during the forecast period.

Molbio Diagnostics stock jumped 29% on its market debut. The point-of-care diagnostics firm''s Rs 940-crore IPO saw strong ...

Molbio Diagnostics shares surge over 21% in debut, achieving a market valuation of ₹10,875.77 crore on the BSE.

Takeda's dengue vaccine may show up on certain dengue fever panels. But knowing when this is normal and when it is related to ...

Molbio Diagnostics shares surged over 21% on their market debut, listing at Rs 980. The IPO was subscribed 70.26 times. Learn ...

Molbio Diagnostics Ltd's shares jumped by over 21% in their market debut, starting at Rs 980 after an IPO that was 70.26 ...

The FDA has approved mFlusiva, the first mRNA-based influenza vaccine, for adults aged 50 years and older, with accelerated approval for those 65 and older.

New research suggests that thistle, long known as a medicinal plant that supports liver health, may also help prevent acute ...

Female Genital Schistosomiasis (FGS) is an often-overlooked reproductive health condition caused predominantly by Schistosoma ...